Why China's expanding pharma market is still a risky bet

China's pharmaceutical market is expanding rapidly, but recent policy developments mean multinationals need to rethink their strategy

4 minute readJuly 21, 2012 at 12:58 AM
By
clpstaff
& clp articles

Statistics from CITI predict China will have a $200 billion pharmaceutical market by 2020, making it the second largest in the world. “This begs the question can multinationals afford not to expand considering how fast the market is growing compared to the global market?”

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

  • ✓ A database of 3000+ essential documents, including key PRC laws translated into English
  • ✓ Newsletters with business-critical and sector-specific updates
  • ✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)